Hellerup, Denmark

Henrik Egesborg

This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 8 EPO patents. Top assignees: Ascendis Pharma A/s, Ascendis Pharma Endocrinology Division A/s, Medtronic Minimed, Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Egesborg. Retrieved from https://idiyas.com/inventor/henrik-egesborg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Henrik Egesborg - Innovative Danish Inventor

Introduction: Henrik Egesborg is a renowned inventor hailing from Hellerup, Denmark, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Henrik Egesborg holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to developing solutions for a greener future.

Career Highlights: With a career spanning over two decades, Henrik Egesborg has worked tirelessly to bring his ideas to life, revolutionizing industries with his inventive concepts and cutting-edge designs.

Collaborations: Throughout his career, Henrik Egesborg has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Henrik Egesborg's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of creators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…